Leadership changes at Dutch biotech firm

Eric Goossens joins gene therapy company uniQure (QURE +0.8%) as Chief Operating Officer. Previously, he was Site Director for Datwyler Pharma Packaging.

Deya Corzo, M.D. joins the firm as VP, Medical Affairs for the U.S. She was previously with Celgene.

Piers Morgan, CFO, will leave the company on May 20 to pursue other interests. The search for his replacement is underway.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs